161 related articles for article (PubMed ID: 8932455)
1. Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A.
Calvo P; Sanchez A; Martinez J; Lopez MI; Calonge M; Pastor JC; Alonso MJ
Pharm Res; 1996 Feb; 13(2):311-5. PubMed ID: 8932455
[TBL] [Abstract][Full Text] [Related]
2. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.
De Campos AM; Sánchez A; Alonso MJ
Int J Pharm; 2001 Aug; 224(1-2):159-68. PubMed ID: 11472825
[TBL] [Abstract][Full Text] [Related]
3. Treatment of endotoxin-induced uveitis by topical application of cyclosporine a-loaded PolyGel™ in rabbit eyes.
Alshamsan A; Abul Kalam M; Vakili MR; Binkhathlan Z; Raish M; Ali R; Alturki TA; Safaei Nikouei N; Lavasanifar A
Int J Pharm; 2019 Oct; 569():118573. PubMed ID: 31356955
[TBL] [Abstract][Full Text] [Related]
4. A polycaprolactone nanoparticle formulation of cyclosporin-A improves the prediction of area under the curve using a limited sampling strategy.
Molpeceres J; Chacón M; Guzmán M; Berges L; del Rosario Aberturas M
Int J Pharm; 1999 Sep; 187(1):101-13. PubMed ID: 10502617
[TBL] [Abstract][Full Text] [Related]
5. [Preparation of cyclosporine A loaded mPEG-PLGA copolymer micelles and study its pharmacokinetics in rats].
Yao DG; Sun KX; Mu HJ; Zhou FM; Chen HH; Liu LJ; Liang N
Yao Xue Xue Bao; 2009 Dec; 44(12):1410-5. PubMed ID: 21351479
[TBL] [Abstract][Full Text] [Related]
6. Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol.
Losa C; Marchal-Heussler L; Orallo F; Vila Jato JL; Alonso MJ
Pharm Res; 1993 Jan; 10(1):80-7. PubMed ID: 8094245
[TBL] [Abstract][Full Text] [Related]
7. Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution.
Shen J; Deng Y; Jin X; Ping Q; Su Z; Li L
Int J Pharm; 2010 Dec; 402(1-2):248-53. PubMed ID: 20934499
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclosporine A formulations on bovine corneal absorption: ex-vivo study.
Le Bourlais CA; Chevanne F; Turlin B; Acar L; Zia H; Sado PA; Needham TE; Leverge R
J Microencapsul; 1997; 14(4):457-67. PubMed ID: 9229345
[TBL] [Abstract][Full Text] [Related]
9. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
Yang ZQ; Xu J; Pan P; Zhang XN
Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat.
Juberías JR; Calonge M; Gómez S; López MI; Calvo P; Herreras JM; Alonso MJ
Curr Eye Res; 1998 Jan; 17(1):39-46. PubMed ID: 9472469
[TBL] [Abstract][Full Text] [Related]
11. Polymeric nanocapsules with SEDDS oil-core for the controlled and enhanced oral absorption of cyclosporine.
Park MJ; Balakrishnan P; Yang SG
Int J Pharm; 2013 Jan; 441(1-2):757-64. PubMed ID: 23089581
[TBL] [Abstract][Full Text] [Related]
12. The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa.
De Campos AM; Sánchez A; Gref R; Calvo P; Alonso MJ
Eur J Pharm Sci; 2003 Sep; 20(1):73-81. PubMed ID: 13678795
[TBL] [Abstract][Full Text] [Related]
13. A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation.
Di Tommaso C; Valamanesh F; Miller F; Furrer P; Rodriguez-Aller M; Behar-Cohen F; Gurny R; Möller M
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2292-9. PubMed ID: 22427552
[TBL] [Abstract][Full Text] [Related]
14. Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs.
Agarwal P; Scherer D; Günther B; Rupenthal ID
Int J Pharm; 2018 Mar; 538(1-2):119-129. PubMed ID: 29339249
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers.
Calvo P; Vila-Jato JL; Alonso MJ
J Pharm Sci; 1996 May; 85(5):530-6. PubMed ID: 8742946
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea.
Yenice I; Mocan MC; Palaska E; Bochot A; Bilensoy E; Vural I; Irkeç M; Hincal AA
Exp Eye Res; 2008 Sep; 87(3):162-7. PubMed ID: 18675411
[TBL] [Abstract][Full Text] [Related]
17. Enhanced and sustained topical ocular delivery of cyclosporine A in thermosensitive hyaluronic acid-based in situ forming microgels.
Wu Y; Yao J; Zhou J; Dahmani FZ
Int J Nanomedicine; 2013; 8():3587-601. PubMed ID: 24092975
[TBL] [Abstract][Full Text] [Related]
18. Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: Design, optimization, and in vitro/ex vivo evaluation.
Alvarez-Trabado J; López-García A; Martín-Pastor M; Diebold Y; Sanchez A
Int J Pharm; 2018 Jul; 546(1-2):20-30. PubMed ID: 29753904
[TBL] [Abstract][Full Text] [Related]
19. [The immunosuppressive effects of 0.025% cyclosporin eye drops in alpha cyclodextrin on rabbit corneal allografts].
Takano T; Kobayashi C; Alba RM; Kanai A
Nippon Ganka Gakkai Zasshi; 1992 Jul; 96(7):834-40. PubMed ID: 1502981
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable nanoparticles as a delivery system for cyclosporine: preparation and characterization.
Molpeceres J; Aberturas MR; Guzman M
J Microencapsul; 2000; 17(5):599-614. PubMed ID: 11038119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
